US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Peter Rands

Recent news which mentions Peter Rands

Small Pharma Obtains U.S. Patent For Injectable DMT, First In Company's Psychedelic Portfolio
Tickers DMTTF
Tags Psychedelics Peter Rands Legal
From Benzinga
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know
Tickers BMY CMPS DMTTF GS
Tags Kabir Nath GS DMTTF
From Benzinga
DMT Therapy Developer Small Pharma Posts Financial Results, Reaffirms Potential Of Short-Acting Psychedelics
Tickers DMTTF
Tags Peter Rands Markets Psychedelics
From Benzinga
Small Pharma Receives European Patent Of Ketamine-Based Compounds For Treatment of Depressive Disorders
Tickers DMTTF
Tags General DMTTF News
From Benzinga